|
Volume 271, Number 25,
Issue of June 21, 1996
pp. 15203-15210
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Metabolic and Immunologic Consequences of Limited Adenosine
Deaminase Expression in Mice
(Received for publication, January 24, 1996)
Michael R.
Blackburn
,
Surjit K.
Datta
,
Maki
Wakamiya
¶
,
Bryan S.
Vartabedian
''
and
Rodney E.
Kellems
¶
From the Verna and Marrs McLean Department of
Biochemistry and ¶ Department of Molecular and Human
Genetics and the '' Department of Pediatrics, Baylor College of
Medicine, Houston, Texas 77030
Adenosine deaminase (ADA; EC) deficiency
in humans is an autosomal recessive genetic disorder that results in
severe combined immunodeficiency disease. ADA-deficient mice generated
by targeted gene disruption die perinatally, preventing postnatal
analysis of ADA deficiency. We have recently rescued ADA-deficient
fetuses from perinatal lethality by expression of an ADA minigene in
the placentas of ADA-deficient fetuses, thus generating postnatal mice
admissible to analysis of ADA deficiency. The minigene used also
directed ADA expression to the forestomach postnatally, producing adult
animals that lacked ADA enzymatic activity in all tissues outside the
gastrointestinal tract. Mice with limited ADA expression exhibited
profound disturbances in purine metabolism, including thymus-specific
accumulations of deoxyadenosine and dATP, and inhibition of
S-adenosylhomocysteine hydrolase in the thymus, spleen,
and, to a lesser extent, the liver. Lymphopenia and mild
immunodeficiency were associated with these tissue-specific metabolic
disturbances. These mice represent the first genetic animal model for
ADA deficiency and provide insight into the tissue-specific
requirements of ADA.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Willems, M. E. Reichelt, J. G. Molina, C.-X. Sun, J. L. Chunn, K. J. Ashton, J. Schnermann, M. R. Blackburn, and J. P. Headrick
Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts
Cardiovasc Res,
July 1, 2006;
71(1):
79 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. W. J. Young, J. G. Molina, D. Dimina, H. Zhong, M. Jacobson, L.-N. L. Chan, T.-S. Chan, J. J. Lee, and M. R. Blackburn
A3 Adenosine Receptor Signaling Contributes to Airway Inflammation and Mucus Production in Adenosine Deaminase-Deficient Mice
J. Immunol.,
July 15, 2004;
173(2):
1380 - 1389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Banerjee, H. W. J. Young, J. B. Volmer, and M. R. Blackburn
Gene expression profiling in inflammatory airway disease associated with elevated adenosine
Am J Physiol Lung Cell Mol Physiol,
February 1, 2002;
282(2):
L169 - L182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Blackburn, J. B. Volmer, J. L. Thrasher, H. Zhong, J. R. Crosby, J. J. Lee, and R. E. Kellems
Metabolic Consequences of Adenosine Deaminase Deficiency in Mice Are Associated with Defects in Alveogenesis, Pulmonary Inflammation, and Airway Obstruction
J. Exp. Med.,
July 10, 2000;
192(2):
159 - 170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Baggott, S. L. Morgan, W. M. Sams, and J. Linden
Urinary Adenosine and Aminoimidazolecarboxamide Excretion in Methotrexate-Treated Patients With Psoriasis
Arch Dermatol,
July 1, 1999;
135(7):
813 - 817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Apasov and M. V. Sitkovsky
The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase
Int. Immunol.,
February 1, 1999;
11(2):
179 - 189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Blackburn, S. K. Datta, and R. E. Kellems
Adenosine Deaminase-deficient Mice Generated Using a Two-stage Genetic Engineering Strategy Exhibit a Combined Immunodeficiency
J. Biol. Chem.,
February 27, 1998;
273(9):
5093 - 5100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Koshiba, H. Kojima, S. Huang, S. Apasov, and M. V. Sitkovsky
Memory of Extracellular Adenosine A2A Purinergic Receptor-mediated Signaling in Murine T Cells
J. Biol. Chem.,
October 10, 1997;
272(41):
25881 - 25889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Huang, S. Apasov, M. Koshiba, and M. Sitkovsky
Role of A2a Extracellular Adenosine Receptor-Mediated Signaling in Adenosine-Mediated Inhibition of T-Cell Activation and Expansion
Blood,
August 15, 1997;
90(4):
1600 - 1610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Shi, J. H. Winston, M. R. Blackburn, S. K. Datta, G. Hanten, and R. E. Kellems
Diverse Genetic Regulatory Motifs Required for Murine Adenosine Deaminase Gene Expression in the Placenta
J. Biol. Chem.,
January 24, 1997;
272(4):
2334 - 2341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Blackburn, T. Knudsen, and R. Kellems
Genetically engineered mice demonstrate that adenosine deaminase is essential for early postimplantation development
Development,
January 8, 1997;
124(16):
3089 - 3097.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Blackburn, M. Aldrich, J. B. Volmer, W. Chen, H. Zhong, S. Kelly, M. S. Hershfield, S. K. Datta, and R. E. Kellems
The Use of Enzyme Therapy to Regulate the Metabolic and Phenotypic Consequences of Adenosine Deaminase Deficiency in Mice. DIFFERENTIAL IMPACT ON PULMONARY AND IMMUNOLOGIC ABNORMALITIES
J. Biol. Chem.,
October 6, 2000;
275(41):
32114 - 32121.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|